Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results (Q73192395)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

P P Connell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Ignacio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R B McBride

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R R Weichselbaum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Vijayakumar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

875-879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Beams eye view-based photon radiotherapy I

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900253-8

7 January 2021

10.1016/S0090-4295(99)00253-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565750%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference